Physician profile
Gary E Gansen
NPI 1992170856
$4,548.18
in general payments reported to CMS, 2019-2025
12 companies · $2,506 in 2025
The $2,506 reported for 2025 was more than what 87% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $239 · 2020: $388 · 2021: $264 · 2022: $525 · 2023: $343 · 2024: $284 · 2025: $2,506.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,952 · Food and Beverage: $1,180.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,952.45 |
| Food and Beverage | $1,180.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $1,369.33 | 2022-2025 | |
| Kerecis Limited | $1,360.20 | 2023-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Surgiclose |
| Stryker Corporation | $1,025.03 | 2019-2025 | Citrefix, Augment Injectable, Ortholoc 3di |
| Zimmer Biomet Holdings, INC. | $486.85 | 2019-2021 | |
| Depuy Synthes Sales INC. | $114.68 | 2023 | Fibergraft Aeridyan Matrix, Speedbutton |
| Dynasplint Systems INC. | $47.47 | 2019 | |
| Wardlow Enterprises | $44.13 | 2023 | |
| Prism Medical | $27.14 | 2025 | |
| Smith+Nephew, INC. | $22.47 | 2020-2021 | |
| Paragon 28, INC. | $21.58 | 2020-2021 | |
| Vertex Pharmaceuticals Incorporated | $17.49 | 2025 | |
| Orthofix Medical, INC. | $11.81 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Gansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.